QFIN reported earnings on August 26 into a market already braced for bad news — and JP Morgan just made its position clear.
The most consequential development this week is the JP Morgan downgrade filed this morning. Analyst Katherine Lei cut the rating from Neutral to Underweight and slashed the price target from $13.50 to $9.00 — a move that puts her firmly below the current price of $11.53. That follows a sequence of deteriorating conviction: Lei had already downgraded the stock from Overweight to Neutral in November 2025, cutting the target from $45 to $21, then trimmed again to $13.50 earlier this month. Each step lower has tracked the stock's collapse. The broader analyst community remains constructive in aggregate — five buys, three holds, three outperforms against two negative ratings — but the JP Morgan reversal is notable precisely because this is the same firm that initiated with an Overweight at $65 in mid-2025. That journey from $65 to $9 in thirteen months tells its own story about how sentiment on Chinese fintech has deteriorated. The consensus mean target of $112 looks like a data artefact — almost certainly a currency or stale-target mismatch — and should not be taken at face value.
Options positioning had already been flashing caution ahead of the print. The put/call ratio ran at 0.41 this week, more than two standard deviations above its 20-day average of 0.30, marking the most defensive skew in the near-term data. That elevated hedging followed a punishing month — the stock fell 13% over the past 30 days, recovering partially with a nearly 5% bounce on Tuesday. The borrow market, however, tells a completely different story: availability is running at roughly 1,877% of estimated short interest, meaning shares available to lend outnumber shares already borrowed by a factor of nearly 19. Borrowing costs are negligible at 0.55% annually, well below the brief spike to 1.26% seen on August 14. Short positions have grown about 3% over the past week and 13% over the past month, but from a low enough base that there is no meaningful squeeze dynamic in the lending market.
On valuation, the numbers are striking in isolation. QFIN trades at 2.8x earnings and 0.37x book, with an EV/EBITDA of 1.5x — figures that would typically attract value buyers aggressively. But the factor scores complicate that picture. EPS momentum ranks in just the 11th percentile on a 30-day basis and the 16th on a 90-day view, while analyst recommendation divergence scores near the bottom of the universe at 6. The dividend score, by contrast, is exceptional at the 97th percentile — consistent with the 14% forward yield flagged in recent notes. The short score has edged down to 30.5 from a week-ago reading near 31, suggesting no intensification in short-side pressure despite the analyst downgrade.
On the institutional side, the ownership picture is mixed. BlackRock added roughly 513,000 shares through July, and Triata Capital built a meaningful new position of 1.67 million shares in the June quarter. Arrowstreet added over 1.46 million shares in the same period. Against that, D.E. Shaw trimmed by 602,000 shares and Goldman Sachs cut by 414,000. The net institutional flow is not decisively in either direction. Director-level insider buying in March — two purchases totalling 250,000 shares at prices around $12.50 to $12.89, representing over $3.2 million in net value over 90 days — adds a modest contrarian data point, though the most recent trade in June was a small $57,000 purchase at $14.41, well above the current price.
Peers in Chinese fintech have not offered shelter this week. LU fell 12.4% and LX dropped 3% over the same period, confirming that the sector-wide pressure noted ahead of earnings has not abated. FINV held relatively flat, down just 0.2% on the week. The post-earnings reaction and how the market digests the JP Morgan downgrade — coming on the same day results were released — is now the central question for positioning into next week.
See the live data behind this article on ORTEX.
Open QFIN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
